“Short-term surrogate biomarkers of chronic lesion expansion.” Samuel Klistorner, et al. – University of Sydney To enable predictions of...
Multiple Sclerosis
“Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesions.” Yi-Heng Tai, et al. – Ludwig-Maximilians...
Implication of DNA methylation changes at chromosome 1q21.1 in the brain pathology of Primary Progressive Multiple Sclerosis. Majid Pahlevan...
After laying out a controversial model for the role of EBV in MS, Gavin Giovannoni went a step further...
Early indications from CMSC suggest we are on the verge of major new options for MS treatment. Two signaling...
Biomarkers seemed to be everywhere at CMSC. Presenters discussed the great need for clinical assays that can provide a...
“Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis.” Olivia G. Thomas, et al. – Karolinska...
Proteomic predictors of physical, cognitive and imaging outcomes in multiple sclerosis: 5-year follow-up study. DCI: 1.0. Kian Jalaleddini, et...